Literature DB >> 7666528

A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.

I Ventoso1, L Carrasco.   

Abstract

Four poliovirus mutants with modifications of tyrosine 88 in 2A(pro) were generated and introduced into the cloned poliovirus genome. Mutants Y88P and Y88L were nonviable, mutant Y88F showed a wild-type (WT) phenotype, and mutant Y88S showed a delayed cytopathic effect and formed small plaques in HeLa cells. Growth of Y88S in HeLa cells was restricted, giving rise to about 20% of the PFU production of the WT poliovirus. The 2A (Y88S) mutant synthesized significantly lower levels of viral proteins in HeLa cells than did the WT poliovirus, while the kinetics of p220 cleavage were identical for both viruses. Strikingly, the 2A (Y88S) mutant was unable to cleave 3CD, as shown by analysis of poliovirus proteins labeled with [35S]methionine or immunoblotted with a specific anti-3C serum. The ability of the Y88S mutant to form infectious virus and cleave 3CD can be complemented by the WT poliovirus. Synthesis of viral RNA was diminished in the Y88S mutant but less than the inhibition of translation of viral RNA. Experiments in which guanidine was used to inhibit poliovirus RNA synthesis suggest that the primary defect of the Y88S mutant virus is at the level of poliovirus RNA translation, while viral genome replication is much less affected. Transfection of HeLa cells infected with the WT poliovirus with a luciferase mRNA containing the poliovirus 5' untranslated sequence gives rise to a severalfold increase in luciferase activity. This enhanced translation of leader-luc mRNA was not observed when the transfected cells were infected with the 2A (Y88S) mutant. Moreover, cotransfection with mRNA encoding WT poliovirus 2A(pro) enhanced translation of leader-luc mRNA. This enhancement was much lower upon transfection with mRNA encoding 2A(Y88S), 2A(Y88L), or 2A(Y88P). These findings support the view that 2A(pro) itself, rather than the 3C' and/or 3D' products, is necessary for efficient translation of poliovirus RNA in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666528      PMCID: PMC189526     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol.

Authors:  P L Rodriguez; L Carrasco
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A.

Authors:  S J Hambidge; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.

Authors:  E E Wyckoff; R E Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

4.  Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.

Authors:  C U Hellen; M Fäcke; H G Kräusslich; C K Lee; E Wimmer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Lack of direct correlation between p220 cleavage and the shut-off of host translation after poliovirus infection.

Authors:  L Pérez; L Carrasco
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

6.  The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.

Authors:  D M D'Agostino; B K Felber; J E Harrison; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

7.  Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A.

Authors:  W Sommergruber; H Ahorn; A Zöphel; I Maurer-Fogy; F Fessl; G Schnorrenberg; H D Liebig; D Blaas; E Kuechler; T Skern
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

8.  A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.

Authors:  R Pal-Ghosh; C D Morrow
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Persistent infection of human erythroblastoid cells by poliovirus.

Authors:  R E Lloyd; M Bovee
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

Review 10.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

View more
  14 in total

1.  Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.

Authors:  Iván Ventoso; Miguel Angel Sanz; Susana Molina; Juan José Berlanga; Luis Carrasco; Mariano Esteban
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

2.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Viral translation is coupled to transcription in Sindbis virus-infected cells.

Authors:  Miguel A Sanz; Alfredo Castelló; Luis Carrasco
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

4.  Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.

Authors:  Puck B van Kasteren; Ben A Bailey-Elkin; Terrence W James; Dennis K Ninaber; Corrine Beugeling; Mazdak Khajehpour; Eric J Snijder; Brian L Mark; Marjolein Kikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

5.  Exploration of sequence space as the basis of viral RNA genome segmentation.

Authors:  Elena Moreno; Samuel Ojosnegros; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Celia Perales
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-22       Impact factor: 11.205

6.  Cleavage of eukaryotic translation initiation factor 4G by exogenously added hybrid proteins containing poliovirus 2Apro in HeLa cells: effects on gene expression.

Authors:  I Novoa; L Carrasco
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression.

Authors:  A Barco; E Feduchi; L Carrasco
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells.

Authors:  Juliet M Morrison; Vincent R Racaniello
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Genetic selection of poliovirus 2Apro-binding peptides.

Authors:  I Ventoso; A Barco; L Carrasco
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage.

Authors:  Alfredo Castelló; David Franco; Pablo Moral-López; Juan J Berlanga; Enrique Alvarez; Eckard Wimmer; Luis Carrasco
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.